Rudy Sengupta, NI Test and Analytics Software, Test and Measurement, Emerson discusses NigelAI and future plans.
A rare-disease gene therapy developed in Philadelphia has cleared a major regulatory hurdle, positioning it on an accelerated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback